Correspondence regarding a published study: Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomized trials
- PMID: 37558562
- DOI: 10.1016/j.carrev.2023.07.012
Correspondence regarding a published study: Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomized trials
Conflict of interest statement
Declaration of competing interest Ron Waksman reports serving on the advisory boards of Abbott Vascular, Boston Scientific, Medtronic, Philips IGT, and Pi-Cardia Ltd.; being a consultant for Abbott Vascular, Biotronik, Boston Scientific, Cordis, Medtronic, Philips IGT, Pi-Cardia Ltd., Swiss Interventional Systems/SIS Medical AG, and Transmural Systems Inc.; receiving institutional grant support from Amgen, Biotronik, Boston Scientific, and Philips IGT; and being an investor in MedAlliance and Transmural Systems. Cheng Zhang and Ilan Merdler have no conflicts to disclose.
Comment on
-
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials.Lancet. 2023 Apr 15;401(10384):1293-1301. doi: 10.1016/S0140-6736(23)00215-5. Epub 2023 Mar 6. Lancet. 2023. PMID: 36893777 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
